Uses
BC 11 Hydrobromide, is a selective urokinase (uPA) inhibitor. It inhibits clot lysis without haveing any effect on clot formation. It has also shown to be able to decrease viability of MDA-MB231 breast cancer cells in vitro.
Biological Activity
BC-11 is a potent and selective inhibitor of urokinase (urokinase-plasminogen activator, uPA). BC-11 inhibits clot lysis with no effect on clot formation. BC-11 exhibits anti-fibrotic activity and improves wound healing and scar quality after topical administration in mice.
